Bionature E.A. Limited
Year of establishment 2003. The company supports the development of new biomolecules for the treatment of neuroinflammatory and neurodegenerative diseases, such as the multiple sclerosis and retinopathy. Subsequently it covers all expenses in retaining all relevant patent diplomas.